...
首页> 外文期刊>Cell death & disease. >Role of necroptosis in the pathogenesis of solid organ injury
【24h】

Role of necroptosis in the pathogenesis of solid organ injury

机译:坏死病在实体器官损伤发病机制中的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Necroptosis is a type of regulated cell death dependent on the activity of receptor-interacting serine/threonine-protein (RIP) kinases. However, unlike apoptosis, it is caspase independent. Increasing evidence has implicated necroptosis in the pathogenesis of disease, including ischemic injury, neurodegeneration, viral infection and many others. Key players of the necroptosis signalling pathway are now widely recognized as therapeutic targets. Necrostatins may be developed as potent inhibitors of necroptosis, targeting the activity of RIPK1. Necrostatin-1, the first generation of necrostatins, has been shown to confer potent protective effects in different animal models. This review will summarize novel insights into the involvement of necroptosis in specific injury of different organs, and the therapeutic platform that it provides for treatment.
机译:坏死病是一类受调节的细胞死亡,取决于与受体相互作用的丝氨酸/苏氨酸蛋白(RIP)激酶的活性。但是,与细胞凋亡不同,它与胱天蛋白酶无关。越来越多的证据表明尸检涉及疾病的发病机理,包括缺血性损伤,神经退行性病变,病毒感染等。坏死病信号通路的关键参与者现在被广泛认为是治疗目标。坏死抑制素可能被开发为针对RIPK1活性的有效的坏死性抑制剂。 Necrostatin-1是第一代坏死抑制素,已被证明在不同的动物模型中均具有有效的保护作用。这篇综述将总结坏死病参与不同器官特异性损伤的新颖见解,以及它为治疗提供的治疗平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号